OrigiMed (至本医疗)
Shanghai, China
OrigiMed is a medical science and technology transforming company which focuses on developing new technologies and clinical applications for all types of cancer patients. By carrying out more comprehensive and high-throughput methods, leveraging wholesome bioinformatics analysis and clinical annotation, we identify cancer specific molecular markers and genomic features to guide targeted or immuno-therapy, ultimately aim to fortify the evolution of cancer precision medicine in China.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2016
- Website
- www.origimed.com/
Categories
Only accessible to MedStartr community members.
Join nowWhat do you think of OrigiMed (至本医疗)?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now